EN
登录

为双侧肾母细胞瘤儿童患者寻找最佳治疗方法和强度

Pursuit of the optimal therapeutic approach and intensity for children with bilateral Wilms tumour

Nature 等信源发布 2024-08-27 21:21

可切换为仅中文


AbstractInvestigators from the International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG) report on outcomes of children with bilateral Wilms tumour treated on the SIOP 2001 study. They demonstrate that vincristine and actinomycin-D induction chemotherapy is sufficient in a subset of children, but most required additional agents during their treatment..

摘要国际儿科肿瘤学会肾肿瘤研究小组(SIOP-RTSG)的研究人员报告了SIOP 2001研究中治疗的双侧肾母细胞瘤儿童的结果。他们证明长春新碱和放线菌素D诱导化疗在一部分儿童中是足够的,但大多数在治疗过程中需要额外的药物。。

In both Europe and North America, neoadjuvant chemotherapy and bilateral nephron-sparing surgery are employed in the treatment of bilateral Wilms tumour (BWT) to preserve the greatest possible volume of functioning renal parenchyma [1]. Children with BWT are prone to develop diffuse anaplasia or to experience late disease relapse (>2 years) at higher rates than children with unilateral Wilms tumour [2].

在欧洲和北美,新辅助化疗和双侧肾单位保留手术被用于治疗双侧肾母细胞瘤(BWT),以保留尽可能大的功能性肾实质体积(1)。BWT患儿比单侧肾母细胞瘤患儿更容易发生弥漫性不典型增生或晚期疾病复发(>2年)。

These late relapses may be metachronous, “new” tumours due to germline or mosaic Wilms tumour genetic or epigenetic predisposition in patients with BWT [3, 4]. Furthermore, children with BWT experience higher rates of late renal failure resulting in the need for dialysis or kidney transplant when compared to patients with unilateral Wilms tumour [5].

由于BWT患者的种系或镶嵌Wilms肿瘤遗传或表观遗传易感性,这些晚期复发可能是异时的“新”肿瘤[3,4]。此外,与单侧肾母细胞瘤患者相比,BWT儿童晚期肾衰竭的发生率更高,因此需要透析或肾移植。

Nevertheless, the imperative to preserve kidney function must be balanced against oncologically sound treatment aimed to eradicate tumour and optimise event-free and overall survival. Studies conducted primarily in Europe through the International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG) and in North America through the Children’s Oncology Group (COG) have aimed to determine the optimal therapeutic approach, sequence, and intensity for patients with BWT.In 2017, results were published from the COG Study AREN0534, which was the first prospective, multi-institutional clinical trial for children with BWT [6].

然而,保护肾功能的必要性必须与旨在根除肿瘤并优化无事件和总体生存的肿瘤学合理治疗相平衡。主要通过国际儿科肿瘤学会肾肿瘤研究小组(SIOP-RTSG)在欧洲和通过儿童肿瘤小组(COG)在北美进行的研究旨在确定BWT患者的最佳治疗方法,顺序和强度。2017年,COG研究AREN0534公布了结果,这是第一个针对BWT儿童的前瞻性多机构临床试验(6)。

This study aimed to improve event-free and overall survival while maximising renal preservation in children with BWT by intensifying preoperative chemotherapy to include vincristine, actinomycin-D and doxorubicin (VAD), incorporating information from post-chemotherapy treatment histology to guide intensification of adjuvant chemotherapy when indicated, and emphasising renal preservation using bil.

这项研究旨在通过加强术前化疗,包括长春新碱,放线菌素-D和多柔比星(VAD),结合化疗后治疗组织学的信息,指导辅助化疗的强化,从而提高BWT患儿的无事件生存率和总生存率,同时最大限度地保留肾脏。指示,并强调使用bil保存肾脏。

ReferencesDome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, et al. Advances in Wilms tumor treatment and biology: progress through international collaboration. J Clin Oncol. 2015;33:2999–3007.Article

参考文献Dome JS,Graf N,Geller JI,Fernandez CV,Mullen EA,Spreafico F等。肾母细胞瘤治疗和生物学进展:通过国际合作取得的进展。J临床肿瘤学。2015年;33:2999–3007.文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Charlton J, Irtan S, Bergeron C, Pritchard-Jones K. Bilateral Wilms tumour: a review of clinical and molecular features. Expert Rev Mol Med. 2017;19:e8.Article

Charlton J,Irtan S,Bergeron C,Pritchard-Jones K.双侧肾母细胞瘤:临床和分子特征综述。专家Rev Mol Med。2017;19: e8条款

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Coorens THH, Treger TD, Al-Saadi R, Moore L, Tran MGB, Mitchell TJ, et al. Embryonal precursors of Wilms tumor. Science. 2019;366:1247–51.Article

Coorens THH,Treger TD,Al-Saadi R,Moore L,Tran MGB,Mitchell TJ等。肾母细胞瘤的胚胎前体。科学。2019年;366:1247–51.文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Murphy AJ, Cheng C, Williams J, Shaw TI, Pinto EM, Dieseldorff-Jones K, et al. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children’s Oncology Group AREN18B5-Q. Nat Commun. 2023;14:8006.Article

Murphy AJ,Cheng C,Williams J,Shaw TI,Pinto EM,Dieseldorff-Jones K等。儿童肿瘤组ARN18B5-Q患者双侧肾母细胞瘤易感性的遗传和表观遗传学特征。Nat Commun。2023年;14: 第8006条

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol. 2005;174:1972–5.Article

Breslow NE,Collins AJ,Ritchey ML,Grigoriev YA,Peterson SM,Green DM。肾母细胞瘤患者的终末期肾病:来自国家肾母细胞瘤研究小组和美国肾脏数据系统的结果。J乌拉尔。2005年;174:1972–5.文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Ehrlich P, Chi YY, Chintuagumpala MM, Hoffer FA, Perlman EJ, Kalapurakal JA, et al. Results of the first prospective multi-institutional treatment study in children with bilateral Wilms tumor (AREN0534): a report from the Children’s Oncology Group. Ann Surg. 2017;266:470–8.Article

Ehrlich P,Chi YY,Chintuagumpala MM,Hoffer FA,Perlman EJ,Kalapurakal JA等。第一项双侧肾母细胞瘤儿童前瞻性多机构治疗研究的结果(AREN0534):儿童肿瘤学小组的报告。Ann Surg。2017;

PubMed

PubMed

Google Scholar

谷歌学者

Murphy AJ, Brzezinski J, Renfro LA, Tornwall B, Malek MM, Benedetti DJ, et al. Long-term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally-predisposed unilateral Wilms tumor, a report from the COG AREN0534 study. Int J Cancer. 2024. https://doi.org/10.1002/ijc.35080.

Murphy AJ,Brzezinski J,Renfro LA,Tornwall B,Malek MM,Benedetti DJ等。来自COG AREN0534研究的报告,双侧肾母细胞瘤或双侧易感单侧肾母细胞瘤患者的长期预后和复发模式。Int J癌症。2024https://doi.org/10.1002/ijc.35080.

Online ahead of print.Sudour-Bonnange H, Tinteren van H, Ramírez-Villar GL, Godzinski J, Irtan S, Gessler M, et al. Characteristics and outcome of synchronous bilateral Wilms tumour in theSIOP WT 2001 study: report from the SIOP Renal Tumour Study Group (SIOP-RTSG). Br J Cancer. 2024. https://doi.org/10.1038/s41416-024-02799-0 (this issue).Welter N, Brzezinski J, Treece A, Chintagumpala M, Young MD, Perotti D, et al.

在线领先于print.Sudour-Bonnange H,Tinteren van H,Ramírez-Villar GL,Godzinski J,Irtan S,Gessler M等。SIOP WT 2001研究中同步双侧肾母细胞瘤的特征和结果:SIOP肾肿瘤研究组(SIOP-RTSG)的报告。Br J癌症。2024https://doi.org/10.1038/s41416-024-02799-0(本期)。Welter N,Brzezinski J,Treece A,Chintagumpala M,Young MD,Perotti D等。

The pathophysiology of bilateral and multifocal Wilms tumors: what we can learn from the study of predisposition syndromes. Pediatr Blood Cancer. 2022;70:e29984.Madanat-Harjuoja LM, Renfro LA, Klega K, Tornwall B, Thorner AR, Nag A, et al. Circulating tumor DNA as a biomarker in patients with stage III and IV Wilms tumor: analysis from a Children’s Oncology Group Trial, AREN0533.

双侧和多灶性肾母细胞瘤的病理生理学:我们可以从易感综合征的研究中学到什么。儿科血癌。2022年;70:e29984.Madanat-Harjuoja LM,Renfro LA,Klega K,Tornwall B,Thorner AR,Nag A等。循环肿瘤DNA作为III期和IV期肾母细胞瘤患者的生物标志物:来自儿童肿瘤学组试验的分析,AREN0533。

J Clin Oncol. 2022;40:3047–56.Download referencesAuthor informationAuthors and AffiliationsDepartment of Surgery, St. Jude Children’s Research Hospital, Memphis, TN, USAAndrew J. MurphyDivision of Pediatric Surgery, Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USAAndrew J.

J临床肿瘤学。2022年;40:3047–56.下载参考文献作者信息作者和附属机构美国田纳西州孟菲斯圣裘德儿童研究医院外科Andrew J.Murphy美国田纳西州孟菲斯田纳西大学健康科学中心外科儿科外科Andrew J。

MurphyAuthorsAndrew J. MurphyView author publicationsYou can also search for this author in.

MurphyAuthorsAndrewJ.MurphyView作者出版物您也可以在中搜索此作者。

PubMed Google ScholarContributionsAll contributions were from a single author (AJM). AJM—conceptualisation; writing—initial draft; writing—review and editing.Corresponding authorCorrespondence to

PubMed谷歌学术贡献所有贡献都来自一位作者(AJM)。AJM概念化;撰写初稿;写作评论和编辑。对应作者对应

Andrew J. Murphy.Ethics declarations

安德鲁·J·墨菲。道德宣言

Competing interests

相互竞争的利益

The author declares no competing interests.

作者声明没有利益冲突。

Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Rights and permissionsReprints and permissionsAbout this articleCite this articleMurphy, A.J. Pursuit of the optimal therapeutic approach and intensity for children with bilateral Wilms tumour..

Additional informationPublisher的注释Springer Nature在已发布的地图和机构隶属关系中的管辖权主张方面保持中立。权利和许可打印和许可本文引用本文Murphy,A.J.追求双侧肾母细胞瘤儿童的最佳治疗方法和强度。。

Br J Cancer (2024). https://doi.org/10.1038/s41416-024-02806-4Download citationReceived: 03 July 2024Revised: 08 July 2024Accepted: 22 July 2024Published: 27 August 2024DOI: https://doi.org/10.1038/s41416-024-02806-4Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.

Br J癌症(2024)。https://doi.org/10.1038/s41416-024-02806-4Downloadhttps://doi.org/10.1038/s41416-024-02806-4Share本文与您共享以下链接的任何人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享的链接。复制到剪贴板。

Provided by the Springer Nature SharedIt content-sharing initiative

由Springer Nature SharedIt内容共享计划提供